Abbvie Inc. CFD

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It’s ranked 6th on the list of largest biomedical companies by revenue. The company’s primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), which is administered via injection. It’s approved to treat autoimmune diseases, including rheumatoid arthritis, Crohn’s disease, plaque psoriasis, and ulcerative colitis.